IL6R and ovarian cancer: The data presented herein suggest a rationale for anti-IL-6/IL-6R therapy to suppress the peritoneal spread of ovarian cancer and provide evidence of the therapeutic potential of anti-IL-6R therapy to cure this miserable disease.